In July 2024, European regulators rejected Eisai and Biogen’s anti-amyloid drug Leqembi for early stage Alzheimer’s. By November, they had changed their minds. Now, the…
Your genetics could make you more vulnerable to the side effects of the new class of Alzheimer’s drugs. Carrying two copies of the ApoE4…
Many people experience painful swelling in their joints, especially as they get older. Last year, the CDC reported that more than half of adults…
This article is part of the Journey to Diagnosis series, produced by Being Patient with support provided by Eli Lilly. Living with multiple sclerosis…
When ancient Greek soldiers laid their mythical siege upon the city of Troy, they struggled to break through the city’s impenetrable walls. To finally…
Years before any symptoms of Alzheimer’s appear, beta-amyloid and tau proteins misfold, tangle, and aggregate inside the brain. While many people may develop beta-amyloid…
Traumatic brain injury is one of the world’s leading cause of death and disability. Blunt force trauma to the brain, often from a bad…
Four people living with cognitive decline share their stories. Below, Being Patient features — in a series of short-form documentary videos — people diagnosed…
Approximately one quarter of hospital beds in acute wards – wards for patients who need close care for a sudden or severe medical conditions…
Treatment with a powerful magnet is one of the newest experimental therapies being used to try to turn back the clock on Alzheimer’s disease….
Before Americans become eligible for Medicare at 65, they often rely on private insurance. But for people who start showing signs of Alzheimer’s in…
Why are researchers still fumbling in the quest to cure what is arguably one of the most important diseases confronting humankind — Alzheimer’s disease?…
Loneliness, heart disease, diabetes, and mental health conditions all put older Americans at a higher risk of developing cognitive decline and Alzheimer’s disease. Looking…
Anti-amyloid drugs like Leqembi and Kisunla are on the market for treating early Alzheimer’s disease, but they are expensive, difficult to access, and only…
For people living with TBI, articulating what is happening inside the brain can be challenging. Daniel Avesar went so far as to get a…